A new consensus report on the management of type 1 diabetes in adults was presented recently at the European Association for ...

A new approach targets the B-cell pathway with bispecific antibodies, building on decades of research that establishes the role of B cells and self-reactive antibodies in lupus, systemic sclerosis, ...

Calliditas Therapeutics (Calliditas), an Asahi Kasei company, announced today that new data will be presented at the 2025 American Society of Nephrology Kidney Week, taking place from November 6 to 9 ...

November is National Diabetes Awareness Month, a time to talk about the disease that affects more than 38 million people ...

Determining the type of diabetes a patient has at diagnosis can be challenging, and health care professionals should focus on each patient’s clinical condition when determining initial treatment, ...

Bartoclimab and Aimeropruvat are substances developed by Hanol Biopharma and licensed to Immunovant's parent company, Roivant ...

We take a look at some of the exciting diabetes research developments announced in October 2025, and what the findings could mean for people living with or affected by diabetes.

More parents are asking with autistic children are asking to prescribe leucovorin despite a lack of data about its benefits ...

CHICAGO >> President Donald Trump’s embrace of an old generic drug called leucovorin for use against a rare disorder that causes autism-like symptoms has triggered a surge in demand from parents who ...